ER heart test feedback aims to cut readmissions and deaths in Rapid-Breathing patients

NCT ID NCT05699564

Ongoing Knowledge-focused Sponsor: University Hospital, Akershus Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether giving doctors early results from heart biomarker tests (NT-proBNP and hs-cTnT) along with a structured interpretation note can improve outcomes for patients admitted with rapid breathing (tachypnea). About 574 adults will be randomly assigned to receive this feedback or standard care. The main goal is to see if the feedback extends the time until a patient is readmitted to the hospital or dies from any cause.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: early biomarker testing (NT-proBNP and hs-cTnT) with structured feedback
What this could lead to: If successful, this could show that early biomarker-guided assessments in the ER help reduce hospital readmissions and deaths in patients with rapid breathing.
What could go wrong: This is a single-center pragmatic trial, not a large Phase 3 study. The intervention is informational feedback, not a drug, so the impact may be modest and may not apply to other hospitals.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

heart failure Tachypnea

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEART FAILURE TACHYPNEA

Contacts and locations

Locations

Akershus University Hospital

Lørenskog, Lørenskog, 1478, Norway

More trials for these conditions

Other studies related to the condition(s) this trial covers.